VarmX
PrivateLast Round
M&A
Sep 16, 2024
Total Funding Raised
$87.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VarmX operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Series B Extension round in May 2023.
VarmX is a biotechnology company that develops therapeutic drugs designed to restore blood clotting in bleeding patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VarmX Comparables
Compare VarmX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alveron Pharma | 82% | |
| Azurity Pharmaceuticals | 82% | |
| AstraZeneca | 81% |
For institutional investors. Book with your work email.
VarmX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Sep 16, 2024 | ||||
| Series B Extension | May 25, 2023 | ||||
| Grant | Oct 21, 2021 | ||||
| Series B | Jul 8, 2020 | ||||
| Debt | Jul 2, 2018 | ||||
Series A | Jul 2, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VarmX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lundbeck Foundation | Series B |
| European Innovation Council Fund | Grant, Series B Extension |
| EQT Life Sciences | Series B Extension |
| Lundbeckfonden BioCapital | Series B Extension |
| Ysios Capital | Series B Extension, Series B |
| BioGeneration Ventures | Series B Extension, Series B, Seed, Series A |
| Bgvcat | Series A, Series B Extension, Series B, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 45% MoM.
- Jul 29, 2026
Monthly visitors grew 96% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 15, 2026
The VarmX BV-CSL partnership has been shortlisted for the “Deal of the Year (< EUR 500M)” category at the 2026 European Lifestars Awards, with winners to be announced in the United Kingdom on Nov 16th '26.
- receives_awardSep 15, 2026
VarmX BV receives nominations for scientific innovation in the 2026 Prix Galien USA “Best Startup” Award and, with CSL, for strategic partnership in the “Deal of the Year (< EUR 500M)” category at the 2026 European Lifestars Awards in the Netherlands on Sep 15th '26.
For institutional investors. Book with your work email.
VarmX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VarmX's valuation, stock price, and market status.
Is VarmX a public or private company?
VarmX is a private company.
What is the current stock price of VarmX?
VarmX is a private company, so its shares have no public market price. Caplight tracks VarmX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VarmX worth (valuation)?
Valuation information for VarmX is not publicly available.
Can I buy VarmX stock?
VarmX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VarmX's last funding round?
VarmX's most recent funding round was M&A on September 16, 2024.
Who are the main investors in VarmX?
Key investors in VarmX include European Innovation Council Fund, Ysios Capital, BioGeneration Ventures, Bgvcat, Sound Bioventures.
Will VarmX IPO soon?
No public IPO plans have been announced for VarmX.
How can I track VarmX secondary market activity?
Caplight tracks bids, offers, and trades in VarmX's shares on secondary markets.